Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sectra ABCHIX:SECTBS 100 Days Sales Outstanding is 63.66 as of Apr. 2026, which is 3% above its 10-year median of 61.65. GuruFocus rates CHIX:SECTBS with a GF Score™ of 100/100 and a GF Value™ of kr315.25 (Modestly Undervalued). Among 810 Medical Devices & Instruments companies, Sectra AB ranks better than 54.81% on this metric.
Sectra AB's average Accounts Receivable for the
three
months ended in Apr. 2026 was kr721 Mil. Sectra AB's Revenue for the
three
months ended in Apr. 2026 was kr1,033 Mil.
Hence, Sectra AB's Days Sales Outstanding for the
three
months ended in Apr. 2026 was 63.66.
The historical rank and industry rank for Sectra AB's Days Sales Outstanding or its related term are showing as below:
CHIX:SECTBs'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.93 Med: 61.65 Max: 72.28
Current: 61.78
During the past 13 years, Sectra AB's highest Days Sales Outstanding was 72.28. The lowest was 53.93. And the median was 61.65.
CHIX:SECTBs's Days Sales Outstanding is ranked better than 54.81% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.21
vs CHIX:SECTBs: 61.78
Sectra AB's Days Sales Outstanding
increased
from Apr. 2025 (57.20) to Apr. 2026 (63.66).
Sectra AB (CHIX:SECTBs) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Sectra AB Days Sales Outstanding Related Terms
Sectra AB Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Sectra AB's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SECTBS vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Sectra AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Sectra AB's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB (CHIX:SECTBS) has a Days Sales Outstanding of 63.66 as of Apr. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sectra AB and its competitors. This is near median its historical median of 61.65. Over the past decade, Sectra AB's Days Sales Outstanding has ranged from 53.93 to 72.28. According to the industry distribution chart, Sectra AB ranks #366 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 45.2%.
Is Sectra AB's Days Sales Outstanding too high?
Sectra AB's current Days Sales Outstanding of 63.66 is near median its 10-year median of 61.65. Over the past 10 years, this metric has ranged from a low of 53.93 to a high of 72.28. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.21. Sectra AB's value of 63.66 is 2.4% below this industry median. Based on the distribution chart, Sectra AB ranks #366 out of 810 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sectra AB has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #366 out of 810 companies for Days Sales Outstanding. This puts Sectra AB in the upper half of its industry. The industry median Days Sales Outstanding is 65.21. Sectra AB's value of 63.66 is 2.4% below this benchmark. Historically, Sectra AB's own Days Sales Outstanding has ranged from 53.93 to 72.28 over the past decade. While the company's 10-year median is 61.65 vs. the industry median of 65.21, Sectra AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.21, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current Days Sales Outstanding of 63.66 is 2.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current Days Sales Outstanding is 63.66, which is near median its own 10-year median of 61.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr315.25, compared to a current price of kr279.80 — trading 11.2% below its estimated fair value. The current Days Sales Outstanding is 63.66, which is near median its 10-year median of 61.65 and 2.4% below the Medical Devices & Instruments industry median of 65.21. Sectra AB's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current Days Sales Outstanding is 63.66 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr279.80 is trading 11.2% below its estimated GF Value™ of kr315.25.
GuruFocus considers Sectra AB to be Modestly Undervalued.
Key valuation signals for CHIX:SECTBS:
Days Sales Outstanding: 63.66 (near median its 10-year median of 61.65)
GF Value™: kr315.25 vs. price of kr279.80 (11.2% below fair value)
Industry Position: 2.4% below the Medical Devices & Instruments median (#366 of 810)
No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
100GF Score
Get the complete analysis for CHIX:SECTBS
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SECTBS has been successfully added to your 
